Ipsen Biopharm Limited
$13.1K 5 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Medynus Inc
Medynus Inc reported $13,000.00 across General Payments, Research, and Ownership to 4 physicians and teaching hospitals across 4 transactions.
- $13.0K Below-median payer
- All-tracks total
- 4 Below-median volume
- Transactions
- 4 Below-median reach
- Recipients
- #1602
- of 1,925 companies
Medynus Inc reported $13,000.00 across all CMS Open Payments tracks (General + Research + Ownership) to 4 physicians and teaching hospitals in Program Year 2024 - ranking #1602 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $13,000.00, averaging $3.3K per recipient.
Medynus Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer medynus-inc Medynus Inc
$13.0K · #1602/1,925 · 0.0% industry · PY2024
- TOT $13.0K
- RANK #1602
- SHARE 0.0%
- TXN 4
- RCP 4
- CAT 2
- GEN $13.0K
- TOP1 53.8%
- PY 2024
Volume peers
Nearest volume peer: Ipsen Biopharm Limited ($13.1K)
Medynus Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Medynus Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Medynus Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $7.0K, accounting for 53.8% of this company's General Payments and 1 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Medynus Inc's 2-category general-payment breakdown at $7.0K, 53.8% of the reported total.
How Medynus Inc divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $7.0K | 1 | 53.8% |
| Education | $6.0K | 3 | 46.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $13,000.00 (100.0%) of $13,000.00 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Medynus Inc
The five named recipients with the highest reported General Payments from this company
- 1
James Mok
$7,000.00 across 1 reported transactions
- 2
Daniel Park
$6,000.00 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Medynus Inc ranks #1602 of 1,925 by total payments (bottom 17% by spend) but is notably more concentrated than that alone would suggest -- #356 of 1,838 by HHI (top 19% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Olympus Winter & Ibe GmbH : $34.4K total payments, HHI 5067
- Intellijoint Surgical Inc. : $32.2K total payments, HHI 5059
- McKesson Corporation : $98.3K total payments, HHI 5044
- Teleflex Incorporated : $670.6K total payments, HHI 5042
- nView medical, Inc : $169.96 total payments, HHI 5033
- Asuragen, Inc. : $4.9K total payments, HHI 5032
- Medynus Inc (this company) : $13.0K total payments, HHI 5030
- Spacelabs Healthcare Inc : $3.7K total payments, HHI 5019
- Mighty Oak Medical : $7.2K total payments, HHI 5008
- Ferring SA de CV : $18.0K total payments, HHI 5003
- Cutting Edge Spine, LLC : $13.3K total payments, HHI 5002
- Episurf Medical, Inc. : $15.1K total payments, HHI 5002
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Medynus Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Medynus Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Medynus Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Atrium Medical Corporation
$13.1K 18 recipients
Compare payment profiles
DC Dental, LLC
$12.9K 49 recipients
Compare payment profiles
Uc-Care (usa), Inc
$12.9K 3 recipients
Compare payment profiles
NeurAxis, Inc.
$12.9K 199 recipients
Compare payment profiles
Suture Ease, Inc.
$12.9K 22 recipients
Compare payment profiles
Put this to use
Medynus Inc ranks #1602 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Medynus Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.